Summary
The city stopped covering GLP-1 medications for weight loss starting 2027 after spending ballooned from $470,000 to nearly $3 million in two years. Coverage remains for medical conditions.
At a glance
- Total mentions
- 1
- Last 30 days
- 1
Discussed at 1 meeting in the last 60 days; most recently Oct 28, 2026.
Impact analysis
💰Financial impact
Avoids a projected $4–5 million annual cost.
✅Who benefits
Taxpayers and the self-insured health fund save substantially.
⚠️Who could be affected
City employees seeking weight-loss medication lose that coverage.
Mentions & discussions (1)
We'll email you when it's on an upcoming agenda and when it's voted on, at most once a day.
The weekly brief for Allentown
What the council decided, in plain English — one email a week.
Free. Unsubscribe with one click any time. We never sell your email.